NAD+ Research Guide
Nicotinamide adenine dinucleotide (NAD+) has emerged as one of the most important molecules in aging and metabolic research. This guide provides researchers with a comprehensive overview of NAD+ biology, current research findings, and practical applications in the laboratory.
NAD+ Biosynthesis Pathways
Cells maintain NAD+ levels through multiple biosynthesis pathways:
De Novo Pathway (Kynurenine Pathway)
Synthesizes NAD+ from the essential amino acid tryptophan through an 8-step enzymatic process. This pathway is primarily active in the liver and kidneys.
Salvage Pathway (Preiss-Handler)
Recycles nicotinamide (NAM) — a byproduct of NAD+-consuming enzymes — back to NAD+ through NAMPT (the rate-limiting enzyme) and NMNAT enzymes. This is the dominant pathway for maintaining cellular NAD+ levels.
Nicotinamide Riboside (NR) Pathway
NR is phosphorylated by NRK enzymes to NMN, which is then converted to NAD+ by NMNAT. This pathway has gained attention as a therapeutic target for NAD+ supplementation.
NAD+-Dependent Enzymes
| Enzyme Family | Function | NAD+ Role |
|---|---|---|
| Sirtuins (SIRT1-7) | Deacetylation, ADP-ribosylation | Required substrate |
| PARPs (PARP1-17) | DNA repair, chromatin remodeling | Required substrate |
| CD38/CD157 | Calcium signaling, immune function | Consumed as substrate |
| SARM1 | Axon degeneration pathway | Consumed as substrate |
NAD+ Decline in Aging
Research has documented consistent age-related NAD+ decline:
- Mechanism 1: Increased CD38 expression with age — CD38 is the primary NAD+ consumer in most tissues
- Mechanism 2: Reduced NAMPT activity — the rate-limiting salvage pathway enzyme decreases with age
- Mechanism 3: Chronic inflammation — NF-?B activation drives CD38 upregulation
- Mechanism 4: Accumulated DNA damage — Increased PARP activity consumes more NAD+
Key Research Studies
Aging and Longevity
- Imai & Guarente (2014): Established the NAD+ world concept — NAD+ as a systemic mediator of aging across tissues
- Zhang et al. (2016): NMN supplementation restored NAD+ levels and reversed age-related physiological decline in mice
- Yoshino et al. (2018): Demonstrated NMN improved insulin sensitivity in aged mice through NAD+/SIRT1 pathway
Neuroprotection
- Wang et al. (2016): NAD+ supplementation protected against neurodegeneration in Alzheimer’s disease mouse models
- Hou et al. (2018): NAD+ boosting reduced neuroinflammation and improved cognitive function in aging mice
Cardiovascular
- Zhang et al. (2021): NAD+ repletion improved cardiac function and reduced fibrosis in heart failure models
Human Clinical Trials
- Yoshino et al. (2021): First randomized clinical trial of NMN (250mg/day) showed improved insulin signaling in postmenopausal women with prediabetes
- Multiple Phase I/II trials: NAD+ precursors have shown safety and tolerability in human subjects
Synergistic Research Combinations
NAD+ research often intersects with other compounds targeting similar pathways:
- MOTS-C — Mitochondrial peptide targeting metabolic homeostasis and AMPK activation
- GHK-Cu — Copper peptide with anti-aging and tissue repair properties
- Semax — Neuroprotective peptide for cognitive research
- Resveratrol — SIRT1 activator that may synergize with NAD+ supplementation
Practical Research Considerations
- Storage: Store NAD+ at -20°C in desiccated conditions. Hygroscopic — protect from moisture.
- Stability: NAD+ is pH-sensitive. Most stable at pH 7-8. Degrades rapidly in acidic conditions.
- Measurement: NAD+ can be quantified using enzymatic cycling assays, HPLC, or mass spectrometry.
Frequently Asked Questions
Does NAD+ supplementation increase lifespan?
NAD+ boosting strategies have extended lifespan in yeast, C. elegans, and some mouse models. Human longevity trials are still in early stages.
What depletes NAD+ the most?
CD38, a NAD+-consuming enzyme that increases with age and inflammation, is the primary driver of NAD+ depletion in most tissues.
Related Articles
All products sold by Proxiva Labs are intended for research and laboratory use only. Not for human consumption.